(NASDAQ: ATRC) Atricure's forecast annual revenue growth rate of 11.44% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.2%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.2%.
Atricure's revenue in 2025 is $480,076,000.On average, 4 Wall Street analysts forecast ATRC's revenue for 2025 to be $25,871,730,181, with the lowest ATRC revenue forecast at $25,841,532,222, and the highest ATRC revenue forecast at $25,945,492,409. On average, 4 Wall Street analysts forecast ATRC's revenue for 2026 to be $29,096,476,175, with the lowest ATRC revenue forecast at $28,509,843,691, and the highest ATRC revenue forecast at $29,418,752,755.
In 2027, ATRC is forecast to generate $33,040,824,684 in revenue, with the lowest revenue forecast at $32,960,329,796 and the highest revenue forecast at $33,193,992,693.